Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000
Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000
Helicobacter pylori--Is it a Novel Causative Agent in Vitamin B12 Deficiency?
Arch Int Med 160:1349-1353, 1229, Kaptan,K. et al, 2000
Management of Intracranial Bleeding Associated with Anticoagulation: Balancing the Risk of Further Bleeding Against Thromboembolism From Prosthetic Heart Valves
JNNP 69:396-398, Crawley,F. et al, 2000
Acute Neurologic Decompensation in an Infant With Cobalamin Deficiency Exposed to Nitrous Oxide
J Pediatr 137:427-428, Felmet,K. et al, 2000
Antioxidant Therapy in Neurologic Disease
Arch Neurol 57:1265-1270, Delanty,N. & Dichter,M.A., 2000
Vitamin E and Beta Carotene Supplementation in High Risk for Stroke
Arch Neurol 57:1503-1509, Leppala,J.M.,et al, 2000
Homocysteine and Neurologic Disease
Arch Neurol 57:1422-1428, Diaz-Arrastia,R., 2000
Warfarin-Associated Hemorrhage and Cerebral Amyloid Angiopathy
Neurol 55:947-951, Rosand,J.,et al, 2000
Intake of Flavonoids, Carotenoids,Vitamins C and E, and Risk of Stroke in Male Smokers
Stroke 31:2301-2306, Hirvonen,T.,et al, 2000
Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects
NEJM 343:1608-1614, Hernandez-Dias,S.,et al, 2000
Anticoagulant Patient Information Material Is Written at High Readability Levels
Stroke 31:2966-2970, Estrada,C.A.,et al, 2000
Safety of Discontinuation of Anticoagulation in Patients with Intracranial Hemorrhage at High Thromboembolic Risk
Arch Neurol 57:1710-1713,1682, Phan,T.G.,et al, 2000
Stroke Prevention
Neurol Clin 18:321-341, Wein,T.H. &Bornstein,N.M., 2000
Oral Anticoagulation in Patients with Atrial Fibrillation:Adherence with Guidelines in an Elderly Cohort
Am J Med 106:165-171, White,R.H.,et al, 1999
Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999
Secondary Prevention after Cerebral Ischaemia of Presumed Arterial Origin:Is Aspirin Still the Touchstone?
JNNP 66:557-559, Algra,A.,et al, 1999
Choosing Antithrombotic Therapy for Elderly Patients with Atrial Fibrillation Who are at Risk for Falls
Arch Int Med 159:677-685, Man-Son-Hing,M.,et al, 1999
Preventing Stroke in Patients with Atrial Fibrillation
JAMA 281:1830-1835, Ezekowitz,M.D.&Levine,J.A., 1999
Carotid Artery Tandem Lesions:Frequency of Angiographic Detection and Consequences for Endarterectomy
AJNR 20:621-625, Rouleau,P.A.,et al, 1999
Pregnant, Vomiting, and Coma
Lancet 353:1584, Hillbom,M.,et al, 1999
Risk Assessment and Anticoagulation for Primary Stroke Prevention in Atrial Fibrillation
Stroke 30:1218-1222, Kalra,L.,et al, 1999
Relation of Consumption of Vitamin E, Vitamin C, and Carotenoids to Risk for Stroke among Men in the United States
Ann Int Med 130:963-970, Ascherio,A.,et al, 1999
A Patient Decision Aid Regarding Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation, A Randomized Controlled Trial
JAMA 282:737-743,779, Man-Son-Hing,M.,et al, 1999
Folic Acid for the Prevention of Neural Tube Defects
Pediartrics 104:325-327, Committee on Genetics, 1999
Serum Vitamin A Concentration is Elevated in Idiopathic Intracranial Hypertension
Neurol 53:1114-1118, Jacobson,D.M.,et al, 1999
Primary Prevention of Arterial Thromboembolism in Non-Rheumatic Atrial Fibrillation in Primary Care:Randomised Controlled Trial Comparing Two Intensities of Coumarin with Aspirin
BMJ 319:958-964, Hellemons,B.S.P.,et al, 1999
Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation:A Meta-Analysis
Ann Int Med 131:492-501,537, Hart,R.G.,et al, 1999
Neural-Tube Defects
NEJM 341:1509-1519,1485, Botto,L.D.,et al, 1999
Clinicopath Conf,Thrombosis of St. Jude Medical Aortic Valve,Intra-Cerebral Lobar Hemorrhage, Case 37-1999
NEJM 341:1829-1835, , 1999
Effect of Vitamin C on Frequency of Reflex Sympathetic Dystrophty in Wrist Fractures:A Randomised Trial
Lancet 354:2025-2028, Zollinger,P.E.,et al, 1999
Efficient Operation of a High-Volume Anticoagulation Clinic
Am J Health Syst Pharm 56:443-449, Foss,M.T.,et al, 1999
Frequency of Major Complications of Aspirin,Warfarin,and Intravenous Heparin for Secondary Stroke Prevention,A Population-Based Study
Ann Int Med 130:14-22, Petty,G.W.,et al, 1999
A Woman Who Left Her Wheelchair
Lancet 353:806, Mingrone,G.,et al, 1999
Spastic Paraparesis after Anaesthesia
Lancet 353:554, Lee,P.,et al, 1999
Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
Analysis of Prenatal and Gestational Care Given to Women with Epilepsy
Neurol 51:1039-1045, Seale,C.G.,et al, 1998
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Pregnant,Vomiting,and Going Blind
Lancet 352:1594, Tesfaye,S.,et al, 1998
Mobile Aortic Atheroma & Systemic Emboli:Efficacy of Anticoag & Influence of Plaque Morphol on Recurr Stroke
J Am Coll Cardiol 31:134-138, Dressler,F.A.,et al, 1998
Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
JAMA 279:657-662, 7021998., Hylek,E.M.,et al, 1998
Warfarin Use Following Ischemic Stroke Among Medicare Patients with Atrial Fibrillation
Arch Int Med 158:2093-2100, Brass,L.A.,et al, 1998
MRI of Spinal Cord and Brain Lesions in Subacute Combined Degeneration
Neuroradiology 11:716-719, Katsaros,V.K.,et al, 1998
Oral or Parenteral Therapy for B12 Deficiency
Lancet 352:1721-1722, Elia,M., 1998
Differences in Medical & Surgical Therapy for Stroke Prevention Between Experts in N. America & Europe
Stroke 29:339-345, Masuhr,F.,et al, 1998
Effectiveness of High-Dose Riboflavin in Migraine Prophylaxis, A Randomized Controlled Trial
Neurol 50:466-470, Schoenen,J.,et al, 1998
Morality in DATATOP:A Multicenter Trial in Early Parkinson's Disease
Parkinson Study Group, Ann Neurol 43:318-3251998., , 1998
Marchiafava-Bignami Disease:Reversibility of Neuroimaging Abnormality
J Comput Assist Tomogr 22:503-504, Gass,A.,et al, 1998
Prognosis of Patients with Symptomatic Vertebral or Basilar Artery Stenosis
WASID Study Group, Stroke 29:1389-13921998., , 1998
Cost-Effectiveness of Anticoagulation in Nonrheumatic A Fib in the Primary Prevention of Ischemic Stroke
Stroke 29:1827-1832, Lightowlers,S.&McGuire,A., 1998